Guidant stock sales may fuel shareholder lawsuits: 4 insiders have cashed in more than $91M in shares
Top Guidant Corp. insiders have unloaded more than $100 million in company stock in recent months, a move that will blunt the financial impact they’ll feel if the Indianapolis company and Johnson & Johnson renegotiate the terms of their $25.4 billion merger. The sales also will serve as grist for class-action attorneys, who filed several lawsuits this summer charging insiders concealed from investors defects in the company’s heart devices. By not promptly disclosing defects publicly, one classaction suit filed in…